Skip to main content
. 2022 Sep 30;19(3):838–846. doi: 10.14245/ns.2244464.232

Fig. 1.

Fig. 1.

Flow diagram showing study enrollment, allocation, follow-up, and analysis. rhBMP-2, recombinant human bone morphogenetic protein-2; HA, hydroxyapatite.